This paper is only available as a PDF. To read, Please Download here.
Tissue type plasminogen activator (t-PA) is an effective thrombolytic agent in experimental animals and in humans. We have previously observed that the thrombolytic effect of t-PA persists beyond its time of clearance from the circulation and that wound bleeding induced by a high dose infusion of t-PA is delayed for at least one and a half hours after commencing the infusion. These observations suggest that improved thrombolysis may be obtained with t-PA by infusing a high dose over a short period of time. To test this hypothesis we compared the thrombolytic and hemorrhagic effects of t-PA infused over 240, 60, 30 and 15 minutes in the rabbit.
A 4 hour infusion of 30, 000 U/kg of t-PA produced 36% thrombolysis. The same dose of t-PA infused over 60, 30 and 15 minutes produced 87%, 88% and 96% thrombolysis, respectively (p<0.01). The 1 hour infusion of 30, 000 U/kg of t-PA produced a significant increase in blood loss relative to saline infusion (p<0.01). The same dose infused over 30 and 15 minutes did not produce significantly more bleeding than saline. A higher dose of t-PA, 60, 000 U/kg, infused over 4 hours, produced 95% thrombolysis, but was associated with a significant increase of blood loss (p<0.001).
Our findings suggest that improved thrombolysis with t-PA with minimal bleeding side-effects is achieved in rabbits when t-PA is administered in a relatively high dose given over a short period of time.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Thrombosis Research
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus.Nature. 1981; 291: 590-591
- Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.J. Clin. Invest. 1982; 69: 573-580
- Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis.J. Clin. Invest. 1983; 71: 368-376
- Clot-selective thrombolysis with tissue-type plasminogen activator.Science. 1983; 220: 1181-1183
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation. 1984; 69: 605-610
- Coronary thrombolysis with recombinant human tissue plasminogen activator.Circulation. 1984; 70: 700-707
- Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator.Lancet. 1981; ii: 1018-1020
- Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.N. Engl. J. Med. 1984; 310: 609-613
- Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase.Circulation. 1984; 69: 983-990
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator.Circulation. 1984; 70 (abst.): 27
- Sustained thrombolysis with DNA-recombinant tissue-type plasminogen activator in rabbits.Blood August. 1985; (in press)
- A comparison of the thrombolytic effect of tissue plasminogen activator and streptokinase in rabbits.Circulation. 1985; (in press)
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coll.Nature. 1983; 301: 214-221
- Fibrinogen catabolism: Kinetics of catabolism following sudden elevation of the pool with exogenous fibrinogen.Clin. Sci. 1970; 38: 111-121
- Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate.Scand. J. Clin. Lab. Invest. 1977; 37: 403-409
- Statistical Principles in Experimental Design.in: McGraw Hill, New York1971: 191-196
- A multiple comparison procedure for comparing several treatments with a control.Am. Statist. Assoc. J. 1955; 50: 1096-1121
- On the regulation and control of fibrinolysis.Thromb. Haemostas. 1980; 43: 77-89
- Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.Blood. 1984; 64: 907-913
Accepted: September 8, 1985
Received: June 5, 1985
© 1985 Published by Elsevier Inc.